<DOC>
	<DOCNO>NCT01782495</DOCNO>
	<brief_summary>This study evaluate chronic Hepatitis C Virus infection .</brief_summary>
	<brief_title>A Study Evaluate Chronic Hepatitis C Infection Adult Transplant Recipients</brief_title>
	<detailed_description>The purpose study evaluate safety efficacy ABT-450 , ritonavir , ABT-267 ( ABT-450/r/ABT-267 ) without ABT-333 without ribavirin adult transplant recipient hepatitis C virus ( HCV ) infection .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>1 . Male female , least 18 year age time screen . 2 . Currently take immunosuppressant regimen base either tacrolimus cyclosporine . Corticosteroids prednisone prednisolone permit component immunosuppressant regimen provide dose 10 mg/day . 3 . HCV IFN therapy treatmentna√Øve experience , either pre post liver renal transplant . 4 . Screening HCV genotype test indicate infection genotype 1 4 HCV . 1 . Use everolimus sirolimus part immunosuppressive regimen within 2 month Screening Visit . 2 . Use medication list well contraindicate use either ritonavir RBV within 2 week prior study drug administration 10 halflives ( know ) , whichever longer . 3 . Positive test result Hepatitis B surface antigen ( HBsAg ) antihuman immunodeficiency virus antibody ( HIV Ab ) . 4 . Documented history posttransplant complication directly involve hepatic renal vasculature appropriate organ transplant , e.g. , thrombosis portal vein , hepatic artery and/or hepatic vein . 5 . Clinically significant abnormality , HCV infection , subject posttransplant base upon medical history , physical examination , vital sign , laboratory profile 12lead electrocardiogram ( ECG ) make subject unsuitable candidate study opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>115 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hepatitis C Genotype 4</keyword>
	<keyword>Chronic Hepatitis</keyword>
	<keyword>Interferon-Free</keyword>
	<keyword>Hepatitis C Virus</keyword>
	<keyword>Renal Transplant</keyword>
	<keyword>Liver Transplant</keyword>
	<keyword>Hepatitis C Genotype 1</keyword>
</DOC>